Menu
    • Home
    • Company
    • Our Science
    • Pipeline
    • Press Release
    • Investors
    • Publications
    • Contact
    • Careers
    • Twitter
    • Email
Home
publications
April 21, 2026
Publication, publications
RedTail
CLD-401, an IL-15 superagonist gene medicine via redtail virotherapy, achieves sustained tumor eradication
 
April 19, 2026
Publication, publications
RedTail
Redtail: A dual-programmable virotherapy platform for systemic tumor targeting and localized gene delivery
 

Committed to being at the forefront of cutting-edge research and innovation in the realm of oncology.

Company
  • Home
  • Company
  • Press Release
  • Careers
  • Investors
Science
  • Redtail
  • CLD-401
  • Going Forward
  • Publications
  • Pipeline
Legal
  • Privacy Policy
  • Cookie Policy
  • DSARDo
  • Do Not Sell or Share My Information
Instagram
LinkedIn
X
Vimeo
info@calidibio.com

© 2026 Calidi Biotherapeutics, Inc. All Rights Reserved.

Web Design by Appnet.com | Sitemap